img

Global Injectable Anticoagulants Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Injectable Anticoagulants Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
Injectable Anticoagulants report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Injectable Anticoagulants market is projected to reach US$ 7058.3 million in 2034, increasing from US$ 6092 million in 2022, with the CAGR of 2.1% during the period of 2024 to 2034. Demand from VTE and ACS/MI are the major drivers for the industry.
Market competition is intense. Sanofi, Genentech (Roche), Boehringer Ingelheim and Pfizer, etc. are the leaders of the industry, with about 68% market shares.
North America is the largest consumption place, with a consumption market share nearly 34%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Injectable Anticoagulants market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
Segment by Type
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Others

Segment by Application


VTE
ACS/MI
AF
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Injectable Anticoagulants market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Injectable Anticoagulants introduction, etc. Injectable Anticoagulants Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Injectable Anticoagulants market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Injectable Anticoagulants
1.1 Injectable Anticoagulants Market Overview
1.1.1 Injectable Anticoagulants Product Scope
1.1.2 Injectable Anticoagulants Market Status and Outlook
1.2 Global Injectable Anticoagulants Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Injectable Anticoagulants Market Size by Region (2018-2034)
1.4 Global Injectable Anticoagulants Historic Market Size by Region (2018-2024)
1.5 Global Injectable Anticoagulants Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Injectable Anticoagulants Market Size (2018-2034)
1.6.1 North America Injectable Anticoagulants Market Size (2018-2034)
1.6.2 Europe Injectable Anticoagulants Market Size (2018-2034)
1.6.3 Asia-Pacific Injectable Anticoagulants Market Size (2018-2034)
1.6.4 Latin America Injectable Anticoagulants Market Size (2018-2034)
1.6.5 Middle East & Africa Injectable Anticoagulants Market Size (2018-2034)
2 Injectable Anticoagulants Market by Type
2.1 Introduction
2.1.1 Low-Molecular-Weight Heparin (LMWH)
2.1.2 Direct Thrombin Inhibitor (DTI)
2.1.3 Others
2.2 Global Injectable Anticoagulants Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Injectable Anticoagulants Historic Market Size by Type (2018-2024)
2.2.2 Global Injectable Anticoagulants Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Injectable Anticoagulants Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Injectable Anticoagulants Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Injectable Anticoagulants Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Injectable Anticoagulants Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Injectable Anticoagulants Revenue Breakdown by Type (2018-2034)
3 Injectable Anticoagulants Market Overview by Application
3.1 Introduction
3.1.1 VTE
3.1.2 ACS/MI
3.1.3 AF
3.1.4 Others
3.2 Global Injectable Anticoagulants Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Injectable Anticoagulants Historic Market Size by Application (2018-2024)
3.2.2 Global Injectable Anticoagulants Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Injectable Anticoagulants Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Injectable Anticoagulants Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Injectable Anticoagulants Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Injectable Anticoagulants Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Injectable Anticoagulants Revenue Breakdown by Application (2018-2034)
4 Injectable Anticoagulants Competition Analysis by Players
4.1 Global Injectable Anticoagulants Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Anticoagulants as of 2022)
4.3 Date of Key Players Enter into Injectable Anticoagulants Market
4.4 Global Top Players Injectable Anticoagulants Headquarters and Area Served
4.5 Key Players Injectable Anticoagulants Product Solution and Service
4.6 Competitive Status
4.6.1 Injectable Anticoagulants Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Injectable Anticoagulants Products, Services and Solutions
5.1.4 Sanofi Injectable Anticoagulants Revenue (US$ Million) & (2018-2024)
5.1.5 Sanofi Recent Developments
5.2 Genentech (Roche)
5.2.1 Genentech (Roche) Profile
5.2.2 Genentech (Roche) Main Business
5.2.3 Genentech (Roche) Injectable Anticoagulants Products, Services and Solutions
5.2.4 Genentech (Roche) Injectable Anticoagulants Revenue (US$ Million) & (2018-2024)
5.2.5 Genentech (Roche) Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Profile
5.3.2 Boehringer Ingelheim Main Business
5.3.3 Boehringer Ingelheim Injectable Anticoagulants Products, Services and Solutions
5.3.4 Boehringer Ingelheim Injectable Anticoagulants Revenue (US$ Million) & (2018-2024)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Injectable Anticoagulants Products, Services and Solutions
5.4.4 Pfizer Injectable Anticoagulants Revenue (US$ Million) & (2018-2024)
5.4.5 Pfizer Recent Developments
5.5 The Medicines Company
5.5.1 The Medicines Company Profile
5.5.2 The Medicines Company Main Business
5.5.3 The Medicines Company Injectable Anticoagulants Products, Services and Solutions
5.5.4 The Medicines Company Injectable Anticoagulants Revenue (US$ Million) & (2018-2024)
5.5.5 The Medicines Company Recent Developments
5.6 Aspen
5.6.1 Aspen Profile
5.6.2 Aspen Main Business
5.6.3 Aspen Injectable Anticoagulants Products, Services and Solutions
5.6.4 Aspen Injectable Anticoagulants Revenue (US$ Million) & (2018-2024)
5.6.5 Aspen Recent Developments
5.7 Otsuka
5.7.1 Otsuka Profile
5.7.2 Otsuka Main Business
5.7.3 Otsuka Injectable Anticoagulants Products, Services and Solutions
5.7.4 Otsuka Injectable Anticoagulants Revenue (US$ Million) & (2018-2024)
5.7.5 Otsuka Recent Developments
6 North America
6.1 North America Injectable Anticoagulants Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Injectable Anticoagulants Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Injectable Anticoagulants Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Injectable Anticoagulants Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Injectable Anticoagulants Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Injectable Anticoagulants Market Dynamics
11.1 Injectable Anticoagulants Industry Trends
11.2 Injectable Anticoagulants Market Drivers
11.3 Injectable Anticoagulants Market Challenges
11.4 Injectable Anticoagulants Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Injectable Anticoagulants Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Injectable Anticoagulants Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Injectable Anticoagulants Market Size Share by Region (2018-2024)
Table 4. Global Injectable Anticoagulants Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Injectable Anticoagulants Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Injectable Anticoagulants Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Injectable Anticoagulants Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Injectable Anticoagulants Revenue Market Share by Type (2018-2024)
Table 9. Global Injectable Anticoagulants Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Injectable Anticoagulants Revenue Market Share by Type (2024-2034)
Table 11. North America Injectable Anticoagulants Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Injectable Anticoagulants Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Injectable Anticoagulants Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Injectable Anticoagulants Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Injectable Anticoagulants Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Injectable Anticoagulants Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Injectable Anticoagulants Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Injectable Anticoagulants Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Injectable Anticoagulants Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Injectable Anticoagulants Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Injectable Anticoagulants Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Injectable Anticoagulants Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Injectable Anticoagulants Revenue Market Share by Application (2018-2024)
Table 24. Global Injectable Anticoagulants Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Injectable Anticoagulants Revenue Market Share by Application (2024-2034)
Table 26. North America Injectable Anticoagulants Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Injectable Anticoagulants Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Injectable Anticoagulants Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Injectable Anticoagulants Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Injectable Anticoagulants Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Injectable Anticoagulants Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Injectable Anticoagulants Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Injectable Anticoagulants Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Injectable Anticoagulants Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Injectable Anticoagulants Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Injectable Anticoagulants Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Injectable Anticoagulants Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Anticoagulants as of 2022)
Table 39. Date of Key Players Enter into Injectable Anticoagulants Market
Table 40. Global Injectable Anticoagulants Key Players Headquarters and Area Served
Table 41. Injectable Anticoagulants Product Solution and Service
Table 42. Global Injectable Anticoagulants Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Sanofi Basic Information List
Table 45. Sanofi Description and Business Overview
Table 46. Sanofi Injectable Anticoagulants Products, Services and Solutions
Table 47. Revenue (US$ Million) in Injectable Anticoagulants Business of Sanofi (2018-2024)
Table 48. Sanofi Recent Developments
Table 49. Genentech (Roche) Basic Information List
Table 50. Genentech (Roche) Description and Business Overview
Table 51. Genentech (Roche) Injectable Anticoagulants Products, Services and Solutions
Table 52. Revenue (US$ Million) in Injectable Anticoagulants Business of Genentech (Roche) (2018-2024)
Table 53. Genentech (Roche) Recent Developments
Table 54. Boehringer Ingelheim Basic Information List
Table 55. Boehringer Ingelheim Description and Business Overview
Table 56. Boehringer Ingelheim Injectable Anticoagulants Products, Services and Solutions
Table 57. Revenue (US$ Million) in Injectable Anticoagulants Business of Boehringer Ingelheim (2018-2024)
Table 58. Boehringer Ingelheim Recent Developments
Table 59. Pfizer Basic Information List
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Injectable Anticoagulants Products, Services and Solutions
Table 62. Revenue (US$ Million) in Injectable Anticoagulants Business of Pfizer (2018-2024)
Table 63. Pfizer Recent Developments
Table 64. The Medicines Company Basic Information List
Table 65. The Medicines Company Description and Business Overview
Table 66. The Medicines Company Injectable Anticoagulants Products, Services and Solutions
Table 67. Revenue (US$ Million) in Injectable Anticoagulants Business of The Medicines Company (2018-2024)
Table 68. The Medicines Company Recent Developments
Table 69. Aspen Basic Information List
Table 70. Aspen Description and Business Overview
Table 71. Aspen Injectable Anticoagulants Products, Services and Solutions
Table 72. Revenue (US$ Million) in Injectable Anticoagulants Business of Aspen (2018-2024)
Table 73. Aspen Recent Developments
Table 74. Otsuka Basic Information List
Table 75. Otsuka Description and Business Overview
Table 76. Otsuka Injectable Anticoagulants Products, Services and Solutions
Table 77. Revenue (US$ Million) in Injectable Anticoagulants Business of Otsuka (2018-2024)
Table 78. Otsuka Recent Developments
Table 79. North America Injectable Anticoagulants Market Size by Country (2018-2024) & (US$ Million)
Table 80. North America Injectable Anticoagulants Market Size by Country (2024-2034) & (US$ Million)
Table 81. Europe Injectable Anticoagulants Market Size by Country (2018-2024) & (US$ Million)
Table 82. Europe Injectable Anticoagulants Market Size by Country (2024-2034) & (US$ Million)
Table 83. Asia-Pacific Injectable Anticoagulants Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 84. Asia-Pacific Injectable Anticoagulants Market Size by Region (2018-2024) & (US$ Million)
Table 85. Asia-Pacific Injectable Anticoagulants Market Size by Region (2024-2034) & (US$ Million)
Table 86. Asia-Pacific Injectable Anticoagulants Market Share by Region (2018-2024)
Table 87. Asia-Pacific Injectable Anticoagulants Market Share by Region (2024-2034)
Table 88. Latin America Injectable Anticoagulants Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 89. Latin America Injectable Anticoagulants Market Size by Country (2018-2024) & (US$ Million)
Table 90. Latin America Injectable Anticoagulants Market Size by Country (2024-2034) & (US$ Million)
Table 91. Middle East & Africa Injectable Anticoagulants Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 92. Middle East & Africa Injectable Anticoagulants Market Size by Country (2018-2024) & (US$ Million)
Table 93. Middle East & Africa Injectable Anticoagulants Market Size by Country (2024-2034) & (US$ Million)
Table 94. Injectable Anticoagulants Market Trends
Table 95. Injectable Anticoagulants Market Drivers
Table 96. Injectable Anticoagulants Market Challenges
Table 97. Injectable Anticoagulants Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Anticoagulants Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Injectable Anticoagulants Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Injectable Anticoagulants Market Share by Regions: 2022 VS 2034
Figure 4. Global Injectable Anticoagulants Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Injectable Anticoagulants Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Injectable Anticoagulants Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Injectable Anticoagulants Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Injectable Anticoagulants Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Injectable Anticoagulants Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Low-Molecular-Weight Heparin (LMWH)
Figure 11. Global Low-Molecular-Weight Heparin (LMWH) Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Direct Thrombin Inhibitor (DTI)
Figure 13. Global Direct Thrombin Inhibitor (DTI) Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Global Injectable Anticoagulants Market Size Share by Type: 2022 & 2034
Figure 17. North America Injectable Anticoagulants Revenue Market Share by Type (2018-2034)
Figure 18. Europe Injectable Anticoagulants Revenue Market Share by Type (2018-2034)
Figure 19. Asia-Pacific Injectable Anticoagulants Revenue Market Share by Type (2018-2034)
Figure 20. Latin America Injectable Anticoagulants Revenue Market Share by Type (2018-2034)
Figure 21. Middle East and Africa Injectable Anticoagulants Revenue Market Share by Type (2018-2034)
Figure 22. VTE Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 23. ACS/MI Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 24. AF Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 26. Global Injectable Anticoagulants Market Size Share by Application: 2022 & 2034
Figure 27. North America Injectable Anticoagulants Revenue Market Share by Application (2018-2034)
Figure 28. Europe Injectable Anticoagulants Revenue Market Share by Application (2018-2034)
Figure 29. Asia-Pacific Injectable Anticoagulants Revenue Market Share by Application (2018-2034)
Figure 30. Latin America Injectable Anticoagulants Revenue Market Share by Application (2018-2034)
Figure 31. Middle East and Africa Injectable Anticoagulants Revenue Market Share by Application (2018-2034)
Figure 32. Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 33. Global Top 5 and Top 10 Players Injectable Anticoagulants Market Share in 2022
Figure 34. North America Injectable Anticoagulants Market Share by Country (2018-2034)
Figure 35. U.S. Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 36. Canada Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 37. Germany Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 38. France Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 39. U.K. Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 40. Italy Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 41. Russia Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 42. Nordic Countries Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 43. Asia-Pacific Injectable Anticoagulants Market Share by Region (2018-2034)
Figure 44. China Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 45. Japan Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 46. South Korea Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 47. Southeast Asia Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 48. India Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 49. Australia Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 50. Latin America Injectable Anticoagulants Market Share by Country (2018-2034)
Figure 51. Mexico Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 52. Brazil Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 53. Middle East & Africa Injectable Anticoagulants Market Share by Country (2018-2034)
Figure 54. Turkey Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 56. UAE Injectable Anticoagulants Market Size (2018-2034) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report